Could Far-Flung Mutations in the Genome Activate Cancer-Causing Genes? Ask an Expert!
Thursday, March 20, 2014 - 11:50
in Biology & Nature
A Perspective published with his postdocs, Hans-Martin Herz, Ph.D. and Deqing Hu, Ph.D., in the March 20th issue of Molecular Cell, will serve as the basis for Shilatifard's AACR talk. In it, they summarize how aberrant enhancer activity--due either to mutations in enhancer DNA or in genes that encode proteins that interact with enhancers--may promote oncogenesis.